Prostamax
Also known as: Prostate-Specific Peptide, Prostatic Tissue Bioregulator
⚠
Research-based dosing - under active validation
Based on current literature. Variability exists across study populations.
Under Review
Typical Dosage
20–40 mg/day
Administration
Oral
Administration Schedule
1–2 times daily with food
How It Works
Peptide bioregulator from prostate tissue extract (Khavinson framework). Modulates epithelial cell gene expression and promotes senescent cell apoptosis.
Research Applications
- Prostate tissue health
- Epithelial cell differentiation
- Benign prostatic hyperplasia models
- Prostatic aging research
Research Protocol Summary
Typical Protocol Duration
10–30 days
Half-Life
Not Well Characterized
Protocol Notes
•
Typically 10–30 day courses repeated 1–2x per year.
•
Part of organ-specific bioregulator system.
Citations & Sources
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.